Differential transactivation by the androgen receptor in prostate cancer cells

Prostate

Volumn 36, Issue 4, 1998, Pages 256-263

  Snoek, Robert ^a   Bruchovsky, Nicholas ^a   Kasper, Susan ^b   Matusik, Robert J ^b   Gleave, Martin ^a   Sato, Naohide ^a,c   Mawji, Nasrin R ^a   Rennie, Paul S ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c TEIKYO UNIVERSITY   (Japan)

Author keywords

Androgen receptor; Androgen regulation; Probasin; Prostate cancer; Prostate specific antigen

Indexed keywords

ANDROGEN RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DELETION MUTANT; HUMAN; LIGAND BINDING; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; PROTEIN DOMAIN; TRANSACTIVATION;

ANDROGEN-BINDING PROTEIN; BASE SEQUENCE; BINDING SITES; CELL DIFFERENTIATION; DNA PRIMERS; GENES, REPORTER; HUMANS; LUCIFERASES; MALE; PROMOTER REGIONS (GENETICS); PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; SEQUENCE DELETION; THYMIDINE KINASE; TRANS-ACTIVATION (GENETICS); TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0031838203     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19980901)36:4<256::AID-PROS7>3.0.CO;2-D     Document Type: Article

References (45)

1. Evans RM: The steroid and thyroid hormone receptor superfamily. Science 1988;240:889-895.
2. Truss M, Beato M: Steroid hormone receptors: Interaction with deoxyribonucleic acid and transcription factors. Endocr Rev 1993;14:459-179.
3. Danielian PS, White R, Lees JA, Parker MG: Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. EMBO J 1992; 11:1025-1033.
4. Strahle U, Schmid W, Schutz G: Synergistic action of the glucocorticoid receptor with transcription factors. EMBO J 1988;7: 3389-3395.
5. Chang CS, Kokontis J, Liao ST: Molecular cloning of human and rat complementary DNA encoding androgen receptors. Science 1988;240:324-332.
6. Lubahn DB, Joseph DR, Sar M, Tan J, Higgs HN, Larson RE, French FS, Wilson EM: The human androgen receptor: Complementary deoxyribonucleic acid cloning, sequence analysis and gene expression in prostate. Mol Endocrinol 1988;2:1265-1275.
7. Trapman J, Klaassen P, Kuiper GG, van der Korput JA, Faber PW, van Rooij HC, Geurts van Kessel A, Voorhorst MM, Mulder E, Brinkmann AO: Cloning, structure and expression of a cDNA encoding the human androgen receptor. Biochem Biophys Res Commun 1988;153:241-248.
8. Edwards A, Hammond HA, Jin J, Caskey CT, Chakraborty R: Genetic variation at five trimeric and tetrameric tandem repeat loci in four human population groups. Genomics 1992;12:241-253.
9. Lumbroso R, Beitel LK, Vasiliou DM, Trifiro MA, Pinsky L: Codon-usage variants in the polymorphic (GGN)n trinucleotide repeat of the human androgen receptor gene. Hum Genet 1997; 101:43-16.
10. Irvine RA, Yu MC, Ross RK, Coetzee GA: The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer. Cancer Res 1995;55: 1937-1940.
11. La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH: Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 1991;352:77-79.
12. Giovannucci E, Stampfer MJ, Krithivas K, Brown M, Brufsky A, Talcott J, Hennekens CH, Kantoff PW: The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. Proc Natl Acad Sci USA 1997;94:3320-3323.
13. Stanford JL, Just JJ, Gibbs M, Wicklund KG, Neal CL, Blumenstein BA, Ostrander EA: Polymorphic repeats in the androgen receptor gene: Molecular markers of prostate cancer risk. Cancer Res 1997;57:1194-1198.
14. Hardy DO, Scher HI, Bogenreider T, Sabbatini P, Zhang ZF, Nanus DM, Catterall JF: Androgen receptor CAG repeat lengths in prostate cancer: Correlation with age of onset. J Clin Endocrinol Metab 1996;81:4400-4405.
15. Simental JA, Sar M, Lane MV, French FS, Wilson EM: Transcriptional activation and nuclear targeting signals of the human androgen receptor. J Biol Chem 1991;266:510-518.
16. Palvimo JJ, Kallio PJ, Ikonen T, Mehto M, Janne OA: Dominant negative regulation of trans-activation by the rat androgen receptor: Roles of the N-terminal domain and heterodimer formation. Mol Endocrinol 1993;7:1399-1407.
17. Yen PM, Liu Y, Palvimo JJ, Trifiro M ,Whang J, Pinsky L, Janne OA, Chin WW: Mutant and wild-type androgen receptors exhibit cross-talk on androgen-glucocorticoid-and progesterone-mediated transactivation. Mol Endocrinol 1997;11:162-171.
18. Jenster G, van der Korput HAGM, Trapman J, Brinkmann AO: Identification of two transcription activation units in the N-terminal domain of the human androgen receptor. J Biol Chem 1995;270:7341-7346.
19. Chamberlain NL, Whitacre DC, Miesfeld RC: Delineation of two distinct type 1 activation functions in the androgen receptor amino-terminal domain. J Biol Chem 1996;271:26772-26778.
20. Snoek R, Rennie PS, Kasper S, Matusik RJ, Bruchovsky N: Induction of cell-free, in vitro transcription by recombinant androgen receptor peptides. J Steroid Biochem Mol Biol 1996;59: 243-250.
21. Quigley CA, De Bellis A, Marschke KB, el-Awady MK, Wilson EM, French FS: Androgen receptor defects: Historical, clinical, and molecular perspectives. Endocr Rev 1995;16:271-321.
22. Jenster G, van der Korput HAGM, van Vroonhoven C, van der Kwast TH, Trapman J, Brinkmann AO: Domains of the human androgen receptor involved in steroid binding, transcriptional activation, and subcellular localization. Mol Endocrinol 1991;5: 1396-1404.
23. Langley E, Zhou Z-X, Wilson EM: Evidence for an anti-parallel orientation of the ligand-activated human androgen receptor dimer. J Biol Chem 1995;270:29983-29990.
24. Doesburg P, Kuil CW, Berrevoets CA, Steketee K, Faber PW, Mulder E, Brinkmann AO, Trapman J: Functional in vivo interaction between the amino-terminal, transactivation domain and the ligand binding domain of the androgen receptor. Biochemistry 1997;35:1052-1064.
25. Ikonen T, Palvimo JJ, Janne OA: Interaction between the amino-and carboxyl-terminal regions of the rat androgen receptor modulates transcriptional activity and is influenced by nuclear receptor coactivators. J Biol Chem 1997;272:29821-29828.
26. Horwitz KB, Jackson TA, Bain DL, Richer JK, Takimoto GJ, Tung L: Nuclear receptor coactivators and corepressors. Mol Endocrinol 1996;10:1167-1177.
27. Heery DM, Kalkhoven E, Hoare S, Parker MG: A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature 1997;387:733-736.
28. 70, for the androgen receptor in human prostate cells. Proc Natl Acad Sci USA 1996;93:5517-5521.
29. Voegel JJ, Heine MJS, Zechel C, Chambon P, Gronemeyer H: TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. EMBO J 1996;15:3667-3675.
30. Rennie PS, Bruchovsky N, Leco KJ, Sheppard PC, McQueen SA Cheng H Snoek R, Hamel A, Bock ME, MacDonald BS, Nickel BE, Chang C, Liao S, Cattini PA, Matusik RJ: Characterization of two cis-acting DNA elements involved in the androgen regulation of the probasin gene. Mol Endocrinol 1993;7:23-36.
31. Antras J, Lasnier F, Pairsult J: Adipsin gene expression in 3T3-F442A adipocytes is postranscriptionally down-regulated by retinoic acid. J Biol Chem 1991;266:1157-1161.
32. Claessens F, Alen P, Devos A, Peeters B, Verhoeven G, Rombauts W: The androgen-specific probasin response element 2 interacts differentially with androgen and glucocorticoid receptors. J Biol Chem 1996;271:19013-19016.
33. Tan JA, Joseph DR, Quarmby VE, Lubahn DB, Sar M, French FS, Wilson EM: The rat androgen receptor: Primary structure, autoregulation of its messenger ribonucleic acid, and immunocytochemical localization of the receptor protein. Mol Endocrinol 1988;2:1276-1285.
34. Culig Z, Klocker H, Eberle J, Kaspar F, Hobisch A, Cronauer MV, Bartsch G: DNA sequence of the androgen receptor in prostatic tumor cell lines and tissue specimens assessed by means of the polymerase chain reaction. Prostate 1993;22:11-22.
35. Tilley WD, Bentel JM, Aspinall JO, Hall RE, Horsfall DJ: Evidence for a novel mechanism of androgen resistance in the human prostate cancer cell line, PC-3. Steroids 1995;60:180-186.
36. Berns EMJJ, De Boer W, Mulder E: Androgen-dependent growth regulation of and release of specific protein(s) by the androgen receptor containing human prostate tumor cell line LNCaP. Prostate 1986;9:247-259.
37. Hasenson M, Lundh B, Stege R, Carlstrom K, Pousette A: PAP and PSA in prostatic carcinoma cell lines and aspiration biopsies: Relation to hormone sensitivity and to cytological grading. Prostate 1989;14:83-90.
38. Dodd JG, Sheppard PC, Matusik RJ: Characterization and cloning of rat dorsal prostate mRNAs. Androgen regulation of two closely related abundant mRNAs. J Biol Chem 1983;258:10731-10737.
39. Wang MC, Valenzuela LA, Murphy GP, Chu TM: Purification of a human prostate specific antigen. Invest Urol 1979;17:159-463.
40. Cleutjens KBJM, van Eekelen CCEM, van der Korput HAGM, Brinkmann AO, Trapman J: Two androgen response regions cooperate in steroid hormone regulated activity of the prostate-specific antigen promoter. J Biol Chem 1996;271:6379-6388.
41. Greenberg NM, DeMayo FJ, Sheppard PC, Barrios R, Lebovitz R, Finegold M, Angelopoulou R, Dodd JG, Duckworth ML, Rosen JM, Matusik RJ: The rat probasin gene promoter directs hormonally and developmentally regulated expression of a heterologous gene specifically to the prostate in transgenic mice. Mol Endocrinol 1994;8:230-239.
42. Kasper S, Rennie PS, Bruchovsky N, Sheppard PC, Cheng H, Lin L, Shiu RPC Snoek R, Matusik RJ: Cooperative binding of androgen receptors to two DNA sequences is required for androgen induction of the probasin gene. J Biol Chem 1994;269:31763-31769.
43. Chamberlain NL, Driver ED, Miesfeld RL: The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res 1994;22:3181-3186.
44. Jenster G, de Ruiter PE, van der Korput HAGM, Kuiper GGJM, Trapman J, Brinkmann AO: Changes in the abundance of androgen receptor isotypes: Effects of ligand treatment glutamine-stretch variation, and mutation of putative phosphorylation sites. Biochemistry 1994;33:14064-14072.
45. Gordon DA, Chamberlain NL, Flomerfelt FA, Miesfeld RL: A cell-specific and selective effect on transactivation by the androgen receptor. Exp Cell Res 1995;217:368-377.